Disappearance of enlarged nuchal translucency before 14 weeks' gestation: Relationship with chromosomal abnormalities and pregnancy outcome

Ultrasound in Obstetrics and Gynecology

Volumn 24, Issue 2, 2004, Pages 169-174

  Muller M A ^a   Pajkrt, E ^b   Bleker, O P ^a   Bonsel, G J ^a   Bilardo, C M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Down syndrome; First trimester; NT; Nuchal translucency measurement; Prenatal; Serial; Transient; Ultrasound

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FETUS ECHOGRAPHY; FETUS HYDROPS; FETUS KARYOTYPING; FETUS WASTAGE; GENETIC DISORDER; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROGNOSIS;

ABNORMALITIES; ABORTION, SPONTANEOUS; ADULT; CHROMOSOME ABERRATIONS; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; KARYOTYPING; NECK; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; REMISSION, SPONTANEOUS; ULTRASONOGRAPHY, PRENATAL;

EID: 4043117673     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1103     Document Type: Article

References (28)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304(6831): 867-869.
2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352(9125): 343-346.
3. Pajkrt E, de Graaf IM, Mol BW, van Lith JM, Bleker OP, Bilardo CM. Weekly nuchal translucency measurements in normal fetuses. Obstet Gynecol 1998; 91: 208-211.
4. Pajkrt E, Bilardo CM, van Lith JM, Mol BW, Bleker OP. Nuchal translucency measurement in normal fetuses. Obstet Gynecol 1995; 86: 994-997.
5. Pandya PP, Snijders RJ, Johnson S, Nicolaides KH. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 5: 381-383.
6. Van Zalen-Sprock RM, Van Vugt JM, van Geijn HP. First-trimester diagnosis of cystic hygroma - course and outcome. Am J Obstet Gynecol 1992; 167: 94-98.
7. Chervenak FA, Isaacson G, Blakemore KJ, Breg WR, Hobbins JC, Berkowitz RL, Tortora M, Mayden K, Mahoney MJ. Fetal cystic hygroma. Cause and natural history. N Engl J Med 1983; 309: 822-825.
8. Gustavii B, Edvall H. First-trimester diagnosis of cystic nuchal hygroma. Acta Obstet Gynecol Scand 1984; 63: 377-378.
9. Maymon R, Herman A, Dreazen E, Tovbin Y, Bukovsky I, Weinraub Z. Can nuchal cord cause transient increased nuchal translucency thickness? Hum Reprod 1999; 14: 556-559.
10. Celentano C, Di Donato NG, Prefumo F, Rotmensch S. Early resolution of increased nuchal translucency in a fetus with trisomy 18. Am J Obstet Gynecol 2003; 189: 880-881.
11. Pandya PP, Snijders RJ, Johnson SP, De Lourdes B, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957-962.
12. Huisman TW, Bilardo CM. Transient increase in nuchal translucency thickness and reversed end-diastolic ductus venosus flow in a fetus with trisomy 18. Ultrasound Obstet Gynecol 1997; 10: 397-399.
13. Bilardo CM, Pajkrt E, de Graaf IM, Mol BW, Bleker OP. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998; 11: 401-406.
14. Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995; 5: 15-19.
15. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001; 18: 9-17.
16. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998; 91: 319-323.
17. Hyett J, Moscoso G, Nicolaides K. Increased nuchal translucency in trisomy 21 fetuses: relationship to narrowing of the aortic isthmus. Hum Reprod 1995; 10: 3049-3051.
18. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod 1999; 14: 823-826.
19. Bilardo CM, Muller MA, Pajkrt E. Outcome of fetuses with increased nuchal translucency. Curr Opin Obstet Gynecol 2001; 13: 169-174.
20. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11: 391-400.
21. Haak MC, Bartelings MM, Jackson DG, Webb S, Van Vugt JM, Gittenberger-De Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002; 17: 1086-1092.
22. Bilardo CM, Muller MA, Zikulnig L, Schipper M, Hecher K. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-294.
23. Hyett JA, Perdu M, Sharland GK, Snijders RS, Nicolaides KH. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997; 10: 242-246.
24. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-310.
25. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-268.
26. Cuckle H. Integrating antenatal Down's syndrome screening. Curr Opin Obstet Gynecol 2001; 13: 175-181.
27. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13: 231-237.
28. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001; 358(9294): 1665-1667.